Eton Bioscience: Codex DNA buys Eton Bioscience for $13m as San Diego synthetic biology firms join forces
Deal comes after Codex DNA went public in June at $16 per share, giving it a war chest of $122 million for expansion.
Read full article »
CEO
Eton Bioscience offers biopharmaceutical products such as immunosuppressant antibiotics, protein kinase, nuclease, protease, and metabolism assay kit.
Read more